Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (&#8805; 50%) NSCLC: Real-world Results with Special Focus on PS &#8805; 2, Brain Metastases, and Steroids.

Frost, Nikolaj; Kollmeier, Jens; Misch, Daniel; Vollbrecht, Claudia; Grah, Christian; Matthes, Burkhard; Pultermann, Dennis; Olive, Elisabeth; Raspe, Matthias; Ochsenreither, Sebastian; von Laffert, Maximilian; Suttorp, Norbert; Witzenrath, Martin; Grohé, Christian

Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.

Frost, Nikolaj; Kollmeier, Jens; Misch, Daniel; Vollbrecht, Claudia; Grah, Christian; Matthes, Burkhard; Pultermann, Dennis; Olive, Elisabeth; Raspe, Matthias; Ochsenreither, Sebastian; von Laffert, Maximilian; Suttorp, Norbert; Witzenrath, Martin; Grohé, Christian.

Affiliation

Frost N; Department of Infectious Diseases and Pulmonary Medicine. Electronic address: Nikolaj.frost@charite.de.
Kollmeier J; Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin, Germany.
Misch D; Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin, Germany.
Vollbrecht C; Department of Pathology.
Grah C; Department of Pneumonology, Gemeinschaftskrankenhaus Havelhöhe, Berlin, Germany.
Matthes B; Department of Pneumonology, Gemeinschaftskrankenhaus Havelhöhe, Berlin, Germany.
Pultermann D; Department of Infectious Diseases and Pulmonary Medicine.
Olive E; Klinik für Pneumologie-Evangelische Lungenklinik Berlin Buch, Berlin, Germany.
Raspe M; Department of Infectious Diseases and Pulmonary Medicine.
Ochsenreither S; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
von Laffert M; Department of Pathology.
Suttorp N; Department of Infectious Diseases and Pulmonary Medicine.
Witzenrath M; Department of Infectious Diseases and Pulmonary Medicine.
Grohé C; Klinik für Pneumologie-Evangelische Lungenklinik Berlin Buch, Berlin, Germany.

Clin Lung Cancer ; 22(5): 411-422, 2021 09.

Article de En | MEDLINE | ID: mdl-33648877

Sujet(s)
Mots clés

Checkpoint inhibitors; Nonsmall-cell lung cancer; Real-world data; brain metastases; performance status

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Soins palliatifs / Stéroïdes / Tumeurs du cerveau / Carcinome pulmonaire non à petites cellules / Anticorps monoclonaux humanisés / Antigène CD274 / Antinéoplasiques immunologiques Type d'étude: Clinical_trials Limites: Adult / Aged / Aged80 / Humans / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Clin Lung Cancer Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google